Deepak Sahu, MBA, explains how HEOR studies are important for generating useful effectiveness data for success of medical technologies.
Adoption, utilization, and payment of medical technologies require safety, efficacy, and effectiveness data to convince the purchaser (provider, payer, or patient). In the United States (US) healthcare system, long-term data on effectiveness is critical to maintain payer confidence in the technology and serve the population. Therefore, a well-designed Health Economics and Outcomes Research (HEOR) study is vital for generating short- and long-term effectiveness data. In addition, this webinar discusses a stepwise strategic approach to developing HEOR data for medical technology.
Key Topics Include:
- Learn strategic approach to HEOR in medical devices
- Understand the current framework in the US
- Understand how HEOR is being used to convince various stakeholders including investors
- Understand concepts through a case study
- Analyze relevance of HEOR approach for reimbursement
Presenters
Partner
Alira Health
Deepak Sahu, MBA, focuses on public health and has a strong background in healthcare solutions development. He has more than five years of strategy consulting and project management experience from engagements in Japan, US, and Europe. Deepak holds an MBA from ESB Business School in Germany and Bachelors in Computer Science.
Production Partner
Alira Health
Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle, from development to medical care, through real-world evidence.
Additional Content From HealthEconomics.Com
Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation
In this webinar, Evidera experts present guidance on why strong connections with registry groups and stakeholder populations are important for generating relevant real-world evidence to advance treatments.
Minimizing the Impact of Cross-Cultural Differences in COA Translations
ICON's COA Linguistic Validation Leaders highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.
Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials
Watch a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data.
Related Content
Medicare Part D: Price Negotiation Panel Discussion
Hear expert panelists bring their perspectives on critical issues around support for Medicare Part D products' fair market prices.
What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence
Join three panelists who provide a practical overview of how and why to use data from Medicare for real world studies.
Finding Value in Linking Real-World Data with Social Determinants of Health
Hear Pamela Landsman-Blumberg and Rick Chapman highlight the importance of SDOH and discuss examples of how claims data and EMR linked with SDOH can inform use cases.